参考文献

流行病学

[1]Kingham JG, KocharN, GravenorMB, et al. Incidence, clinical patterns, and outcomes of p rimary sclerosing cholangitis in South Wales,United Kingdom. Gastroenterology. 2004. 126(7):1929-1930.
[2]Bambha K, Kim WR, Talwalkar J, et al. Incidence, clinical spectrum, and outcomes of p rimary sclerosing cholangitis in a United States community. Gastroenterology. 2003. 125(5): 1364-1369.
pubmed摘要
[3]Kap lan GG, Laup land KB, ButznerD, et al. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population2based analysis. Am J Gastroenterol. 2007. 102(5):1042-1049.
[4]Weismüller TJ, Wedemeyer J, Kubicka S, et al. The challenges in primary sclerosing cholangitis- aetiopathogenesis, autoimmunity, management and malignancy. J Hepatol. 2008. 48 (Suppl 1):S382S57.
pubmed摘要
[5]Geonzon-Gonzales MR. Primary sclerosing cholangitis. Gastroenterol Nurs. 2007. 30(2): 102-105.
pubmed摘要
[6]MacFaul GR, Chapman RW. Sclerosing cholangitis. Curr Opin Gastroenterol. 2006. 22(3): 288-293.
pubmed摘要
[7]袁志林, 许昌泰, 潘伯荣, 等. 原发性硬化性胆管炎临床研究现状. 武警医学院学报. 2008. 17(7):632-637.
摘要 | 全文链接 | PDF全文

病因

[1]Weismüller TJ, Wedemeyer J, Kubicka S, et al. The challenges in primary sclerosing cholangitis- aetiopathogenesis, autoimmunity, management and malignancy. J Hepatol. 2008. 48 (Suppl 1):S382S57.
pubmed摘要
[2]周运恒, 杨再兴, 仲人前. 原发性硬化性胆管炎发病机制的研究进展. 中国免疫学杂志. 2008. 24(7):671-673.
摘要 | 全文链接 | PDF全文
[3]Saarinen S, Olerup O, BrooméU, et al. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2000. 95(11) : 3195-3199.
pubmed摘要
[4]Saich R, Chapman R. Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease. World J Gastroenterol. 2008. 14 (3): 331-337.
pubmed摘要 | 全文链接 | PDF全文
[5]Pohl J, RingA, StremmelW, et al. The role of dominant stenoses in bacterial infections of bile ducts in p rimary sclerosing cholangitis. Eur J Gastroenterol Hepatol. 2006. 18(1): 69-74.

病理解剖

[1]Ludwig J, Barham SS, LaRusso NF, et al. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology. 1981. 1(6): 632-640.
pubmed摘要
[2]MacFaul GR, Chapman RW. Sclerosing cholangitis. Curr Opin Gastroenterol. 2006. 22(3): 288-293.
pubmed摘要
[3]袁志林, 许昌泰, 潘伯荣, 等. 原发性硬化性胆管炎临床研究现状. 武警医学院学报. 2008. 17(7):632-637.
摘要 | 全文链接 | PDF全文
[4]Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ; American Association for the Study of Liver Diseases. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010; 51(2):660-678.
pubmed摘要 | 全文链接 | PDF全文
[5]Broome U ,Olsson R ,Loof L ,et al . Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996. 38:610-615.
pubmed摘要 | 全文链接 | PDF全文

问诊与查体

[1] Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ; American Association for the Study of Liver Diseases. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010; 51(2):660-678.

辅助检查

Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ; American Association for the Study of Liver Diseases. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010; 51(2):660-678.

并发症

Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ; American Association for the Study of Liver Diseases. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010; 51(2):660-678.

诊断程序

Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ; American Association for the Study of Liver Diseases. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010; 51(2):660-678.